Q3 2026 guidance -- Revenue of $68 million to $72 million, gross margin of 75% to 76%, adjusted EBITDA of $8 million to $12 million, net income between -$1 million and $3 million, and EPS between ...
Good morning, and welcome to the IDEXX Laboratories First Quarter 2026 Earnings Conference Call. As a reminder, today's conference is being recorded. Participating in the call this morning are Jay ...
Q2 2026 Earnings Call May 8, 2026 8:30 AM EDTCompany ParticipantsClay Whitson - Chief Strategy Officer & DirectorGregory ...
Thursday, May 7, 2026 at 4:30 p.m. ET Chairman and Chief Executive Officer — Joseph C. Sardano President, Chief Commercial ...
Operator: Welcome to Sensus Healthcare, Inc. First Quarter 2026 Financial Results Conference Call. After today ...
The rocket programme may still be on the launchpad, but Scotland’s proven expertise perfectly positions it as a leader in the ...
The rocket programme may still be on the launchpad, but Scotland’s proven expertise perfectly positions it as a leader in the space ...
It's been said before. The depth of this Oklahoma City Thunder team is admirable. General manager Sam Presti has forged this. And while he and Mark Daigneault plug and play to their heart's content ...
As energy companies face tighter compliance demands and leaner budgets, HR teams are ditching bloated ATS platforms for agile, cloud-native solutions. By combining Google Sheets for pipeline tracking, ...
UroGen Pharma Ltd. beats earnings expectations. Reported EPS is $-0.47, expectations were $-0.48244. Operator: Good day, and thank you for standing by. Welcome to the UroGen Pharma Q1 2026 Results ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results